Skip to content

PrEP Pricing Problems

  • Chad Cipiti

A number of barriers to pre-exposure prophylaxis (PrEP) uptake, use, and adherence have been identified—cost shouldn’t be one of them By James Krellenstein and Jeremiah Johnson On July 16, 2012, the U.S. Food and Drug Administration (FDA) approved Gilead Sciences’…

Read more

HIV Community Letter to Hillary for America

  • Chad Cipiti
Dear Secretary Clinton: We write to you in the sincere hope that we can work together to transform the pain caused by your March 11th mischaracterization of the Reagans’ role in the AIDS crisis into an urgently needed public discussion of a plan to end the United States HIV epidemic by the year 2025.
Read more

Pre-CROI Community HIV Cure Research Workshop 2016

  • Chad Cipiti

On Sunday February 21, 2016 in Boston, the AIDS Treatment Activists Coalition, AVAC, European AIDS Treatment Group, Project Inform and TAG co-sponsored a community workshop on HIV cure research. The workshop has become an annual event that takes place immediately…

Read more

Envisioning Comprehensive HIV Prevention Service Delivery in the U.S.

  • Chad Cipiti

RELATED: Toward Comprehensive HIV Prevention Service Delivery in the United States: An Action Plan December 18, 2015 A collaboration between Treatment Action Group and the HIV Prevention Justice Alliance, this webinar discusses the current state of the HIV prevention toolbox…

Read more

2015 TAG Update

  • Chad Cipiti
TAG’s annual review of progress we’ve made on the the fight to end HIV/AIDS, Viral Hepatitis, and Tuberculosis.
Read more

TAG’s Response to Sen. Cassidy Statements on AIDS Research Spending

  • Chad Cipiti
I would like to offer comments to correct the record on statements given by Senator Bill Cassidy (R-LA) at the October 7, 2015, hearing on the National Institutes of Health fiscal year 2016 budget. Several of his comments to the committee and NIH Director Francis Collins were incorrect or misleading. If his erroneous statements about AIDS research funding at the NIH are mistaken for fact, we will set a dangerous course for current and future research being conducted at the agency and undermine the prioritization process under way at the Office of AIDS Research (OAR).
Read more
Back To Top